Silence Therapeutics plc Adjustments For Amortisation Expense
Silence Therapeutics plc (SLNCF) reported Adjustments For Amortisation Expense of GBP 36.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForAmortisationExpense · last filed 2024-03-13
| Period end | Adjustments For Amortisation Expense 12 month |
|---|---|
| 2023-12-31 | 36.00K GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 4.00K GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 16.00K GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 20.00K GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | 30.00K GBP 20-F · filed 2022-03-17 |
| 2018-12-31 | 20.00K GBP 20-F/A · filed 2021-04-29 |